Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in MAGT1 Deficiency

1. Sahin, U, Muik, A, Vogler, I, et al. BNT162b2 Induces SARS-CoV-2-neutralising antibodies and T cells in humans. medRxiv. 2020;2020:1–49.
Google Scholar2. Röltgen, K, Nielsen, SCA, Arunachalam, PS, et al. mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition. medRxiv. 2021;2021:1-33.
Google Scholar3. Tan, CW, Chia, WN, Qin, X, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat Biotechnol. 2020;38:1073–1078.
Google Scholar | Crossref | Medline4. Orange, JS, Ballow, M, Stiehm, ER, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the American academy of allergy, asthma & immunology. J Allergy Clin Immunol. 2012;130(3 Suppl):S1–24.
Google Scholar | Crossref | Medline5. Squire, J, Joshi, A. Seroconversion following COVID-19 vaccination in immune deficient patients. Ann Allergy Asthma Immunol. 2021;127(3):P383-384.
Google Scholar | Medline6. Hagin, D, Freund, T, Navon, M, et al. Immunogenicity of pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. J Allergy Clinical Immunol. 2021;148(3):P739-749.
Google Scholar | Crossref7. Terpos, E, Zagouri, F, Liontos, M, et al. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors. J Hematol Oncol. 2021;14(96):1-4.
Google Scholar | Crossref | Medline8. Ou, MT, Boyarsky, BJ, Chiang, TPY, et al. Immunogenicity and reactogenicity after SARS-CoV-2 mRNA vaccination in kidney transplant recipients taking Belatacept. Transplantation. 2021;105(9):2119-2123.
Google Scholar9. Antall, PM, Meyerson, H, Kaplan, D, Venglarcik, J, Hostoffer, RW. Selective antipolysaccharide antibody deficiency associated with peripheral blood CD5  +  B-cell predominance. J Allergy Clin Immunol. 1999;103(4):637–641.
Google Scholar | Crossref | Medline10. Ravell, JC, Chauvin, SD, He, T, Lenardo, M. An update on XMEN disease. J Clin Immunol. 2020;40(5):671–681.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif